Werewolf Therapeutics

Cambridge, United States

Werewolf Therapeutics operates as an oncology biotherapeutics company.

May 2022

Post-IPO Secondary

Biotechnology Life Science Oncology Therapeutics

Top Investors

RA Capital ManagementAdage Capital ManagementLongwood FundTaiho VenturesDeerfield

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Werewolf Therapeutics

Who are Werewolf Therapeutics's investors?

Werewolf Therapeutics's investors include RA Capital Management, Adage Capital Management, Longwood Fund, Taiho Ventures, Deerfield.

Where is Werewolf Therapeutics headquartered?

Werewolf Therapeutics is headquartered in Cambridge, United States.

What does Werewolf Therapeutics do?

Werewolf Therapeutics operates as an oncology biotherapeutics company.

What stage is Werewolf Therapeutics at?

Werewolf Therapeutics is at the Post-IPO Secondary stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 10, 2022.

MLA

"Werewolf Therapeutics — Funding & Investors." VCBacked, May 10, 2022, https://www.vcbacked.co/company/werewolf-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Werewolf Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/werewolf-therapeutics

Wikipedia (cite web)

{{cite web |title=Werewolf Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/werewolf-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 10, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.